Citadel Advisors’s Aesthetic Medical International Holdings AIH Stock Holding History

Citadel Advisors’s Portfolio AIH Stock Details AIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,363	Closed	-$3.52K	–	15796
2024 Q1	$3.52K	Buy	+11,363	New	+$5.61K	﹤0.01%	13890
2022 Q4	–	Sell	-12,287	Closed	-$21K	–	15624
2022 Q3	$21K	Buy	+12,287	New	+$25.3K	﹤0.01%	12066
2022 Q2	–	Sell	-10,100	Closed	-$16K	–	14430
2022 Q1	$16K	Buy	+10,100	New	+$28.5K	﹤0.01%	13304
2021 Q2	–	Sell	-35,394	Closed	-$261K	–	14630
2021 Q1	$261K	Buy	+35,394	New	+$229K	﹤0.01%	11156

Other funds holding AIH

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Citadel Advisors's AIH Position: Q2 2024 in Review

Citadel Advisors sold out of Aesthetic Medical International Holdings (AIH) in Q2 2024, closing a stake of 11,363 shares — an estimated $3.52K sold.

Citadel Advisors first reported a position in AIH in Q1 2021 and held it in 4 quarters. The position peaked at $261K in Q1 2021. 1 fund tracked by Wall St. Rank holds AIH as of Q2 2024.

Citadel Advisors reported no remaining Aesthetic Medical International Holdings position as of Q2 2024 after selling out during the quarter.
Citadel Advisors sold 11,363 Aesthetic Medical International Holdings shares in Q2 2024, an estimated $3.52K.
Citadel Advisors first reported a position in Aesthetic Medical International Holdings in Q1 2021 and held it in 4 quarters.
Citadel Advisors's Aesthetic Medical International Holdings position peaked at $261K in Q1 2021.
1 fund tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.